# Study of Tocilizumab to Treat Polymyalgia Rheumatica

> **NCT01396317** · PHASE2 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 10 (actual)

## Conditions studied

- Polymyalgia Rheumatica (PMR)

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01396317
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396317, "Study of Tocilizumab to Treat Polymyalgia Rheumatica". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT01396317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*